Health Strategies Group Key Finding #1 9/19/2018 Health Strategies Group Author/Artist Pricing and Ability to Reduce Exacerbations are Most Important Attributes in Stakeholder Access Decisions Health plans acknowledge that lower net pricing is a primary driver of access decisions in COPD, and predictive analysis confirms this. We'll say to the manufacturers, we think you're more similar than different. So from a financial perspective, now it's a horse race based on best pricing or other unique contract terms. – National Plan Pharmacy While net pricing is important, plans also consider other measures that impact finances when making access decisions, such as the total cost of patient care and long-term data on ER/hospitalization reductions. Medical groups are most driven by efficacy scores, reduced hospitalization/ER data, and quality-of- life data in preferred product selection since they are driven by patient outcomes and well-being. COPD patients tend to be older and more fragile than my asthma patients … they can be trickier in terms of preventing the exacerbations and hospitalizations. – Medical Group Primary Care To request slides info@healthstrategies.com